Inovio receives 180-day Nasdaq extension for minimum bid; stock transferred to Capital Market

INOVIO PHARMACEUTICALS, INC.

Extension to April 29, 2024 to achieve $1.00 closing bid for 10 consecutive days.
Common stock transferred from Nasdaq Global Market to Capital Market effective Nov 2, 2023.
Failure to comply by April 29 may lead to delisting; company may appeal the determination.
Company will consider reverse stock split among options to regain compliance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.